News
Amid a reckoning for the gene therapy field, Vertex Pharmaceuticals has joined a growing list of companies paring back their research efforts around the adeno-associated virus (AAV) vectors used ...
Vertex Pharmaceuticals misses analyst estimates on the top and bottom lines in the first quarter. Vertex raises its full-year 2025 revenue guidance to a range of $11.85 billion to $12 billion ...
Vertex Inc (VERX) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Strategic Investments
Unrestricted Cash and Cash Equivalents: Over $270.4 million. Vertex Inc (NASDAQ:VERX) reported a strong start to 2025 with a 12.9% year-over-year increase in revenue, reaching $177.1 million.
Vertex Pharma has teamed up with Orum Therapeutics to develop a conditioning regimen, used to prepare patients to receive gene-editing medicines, that it hopes will offer a more tolerable ...
Abstract: The force-directed quadratic placer ldquoKraftwerk2,rdquo as described in this paper, is based on two main concepts. First, the force that is necessary to distribute the modules on the chip ...
Abstract: We present a new practical stability analysis for a bounded gradient based extremum seeking problem for two variable static quadratic maps that contain a time-varying additive measurement ...
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...
The BVA prescription form has been updated to comply with these changes. Any prescription of antibiotics for prophylactic purposes must now be documented, with the reason for doing so, and a ...
All sections of the form should be filled in as completely as possible. Use a separate form for each patient. Attach an additional form if there is more than one suspected health product. Additional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results